4-oxo-2-nonenal has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, C; Christiansen, G; Grønnemose, AL; Jørgensen, TJD; Mulder, FAA; Nielsen, J; Nowak, JS; Otzen, DE; Pedersen, JN | 1 |
| Andersen, CB; Arnspang, EC; Clausen, MP; Lausdahl, AK; Mulder, FAA; Nielsen, J; Otzen, DE | 1 |
| Almandoz-Gil, L; Bergström, J; Ingelsson, M | 1 |
| Bergström, J; Fagerqvist, T; Ihse, E; Ingelsson, M; Kahle, PJ; Karlsson, M; Kasaryan, A; Lannfelt, L; Lindström, V; Näsström, T; Nikolajeff, F; Outeiro, TF; Sahlin, C; Schell, H; Tucker, SM | 1 |
4 other study(ies) available for 4-oxo-2-nonenal and Parkinson Disease
| Article | Year |
|---|---|
Lipid Peroxidation Products HNE and ONE Promote and Stabilize Alpha-Synuclein Oligomers by Chemical Modifications.
Topics: Aldehydes; alpha-Synuclein; Cell Line, Tumor; Humans; Lipid Peroxidation; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Protein Aggregates; Recombinant Proteins; Scattering, Small Angle; X-Ray Diffraction | 2021 |
4-Oxo-2-nonenal-Induced α-Synuclein Oligomers Interact with Membranes in the Cell, Leading to Mitochondrial Fragmentation.
Topics: Aldehydes; alpha-Synuclein; Humans; Lipid Peroxidation; Parkinson Disease | 2023 |
Generation and Characterization of Stable α-Synuclein Oligomers.
Topics: Aldehydes; alpha-Synuclein; Electrophoresis, Polyacrylamide Gel; Humans; Microscopy, Atomic Force; Parkinson Disease; Protein Multimerization; Protein Stability | 2018 |
Off-pathway α-synuclein oligomers seem to alter α-synuclein turnover in a cell model but lack seeding capability in vivo.
Topics: Aldehydes; alpha-Synuclein; Animals; Brain; Cell Line, Tumor; Humans; Mice; Mice, Transgenic; Microscopy, Atomic Force; Parkinson Disease | 2013 |